Acute myeloid leukemia trials in Brazil
8 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Where
- Barretos, Brasília, Curitiba, Natal, Rio de Janeiro, São Paulo
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06852222 · EU 2024-520154-38-00 - Phase 3Taking peopleMocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
- Where
- Curicica, Florianópolis, São Paulo
- Age
- 18 years to 75 years
- People
- 366 worldwide
- Run by
- Priothera SAS
See details and how to joinNCT05429632 - Phase 3Taking peopleStudy of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Where
- Barretos, Fortaleza, Jaú, Porto Alegre, São Paulo
- Age
- 12 years and over
- People
- 468 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00 - Phase 2Taking peopleEvaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
- Where
- Curitiba, Minas Gerai, Porto Alegre, Rio de Janeiro, San Jose Rio Preto, São Paulo
- Age
- 18 years and over
- People
- 130 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06824168 - Phase 2Taking peopleOral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia
- Where
- São Paulo
- Age
- 18 years to 75 years
- People
- 115
- Run by
- Instituto do Cancer do Estado de São Paulo
See details and how to joinNCT06982274 - Phase 1/2Taking peoplePTCy and ATG for MSD and MUD Transplants
- Where
- Rio de Janeiro
- Age
- 18 years to 60 years
- People
- 50
- Run by
- Instituto Nacional de Cancer, Brazil
See details and how to joinNCT06299462 - Phase 2Not yet taking people in BrazilNK Cell Infusion for Remission Consolidation in AML: A Phase II Trial
- Where
- Porto Alegre
- Age
- 18 years to 75 years
- People
- 98
- Run by
- Hospital de Clinicas de Porto Alegre
See details and how to joinNCT06783478 - Phase 2Taking peopleSafety and Efficacy of Venetoclax, Cytarabine and Metformin (VenCM) for Relapsed-Refractory and Induction-Ineligible Acute Myeloid Leukemia
- Where
- Belém, Curitiba, Florianópolis, Jaú, Joinville
- Age
- 18 years and over
- People
- 100
- Run by
- Hospital Municipal São José
See details and how to joinNCT06537843